Analyzing Health In Tech (HIT) and Its Competitors

Health In Tech (NASDAQ:HIT) is one of 96 public companies in the “Healthcare Technology” industry, but how does it compare to its peers? We will compare Health In Tech to similar companies based on the strength of its analyst recommendations, valuation, institutional ownership, risk, earnings, profitability and dividends.

Insider and Institutional Ownership

41.9% of shares of all “Healthcare Technology” companies are held by institutional investors. 77.7% of Health In Tech shares are held by insiders. Comparatively, 15.8% of shares of all “Healthcare Technology” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility & Risk

Health In Tech has a beta of 2.82, suggesting that its share price is 182% more volatile than the S&P 500. Comparatively, Health In Tech’s peers have a beta of 1.12, suggesting that their average share price is 12% more volatile than the S&P 500.

Profitability

This table compares Health In Tech and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Health In Tech Competitors	-772.01%	-40.91%	-18.12%

Earnings & Valuation

This table compares Health In Tech and its peers revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Health In Tech	$34.08 million	N/A	-56.50
Health In Tech Competitors	$331.32 million	-$23.71 million	11.77

Health In Tech’s peers have higher revenue, but lower earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of current ratings and price targets for Health In Tech and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1	0	0	1	2.50
Health In Tech Competitors	417	1457	2673	87	2.52

Health In Tech presently has a consensus price target of $4.00, indicating a potential upside of 253.98%. As a group, “Healthcare Technology” companies have a potential upside of 55.74%. Given Health In Tech’s higher probable upside, equities research analysts plainly believe Health In Tech is more favorable than its peers.

Summary

Health In Tech beats its peers on 7 of the 12 factors compared.

About Health In Tech

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.